Welcome to wonderful Copenhagen

Strategically located, the Danish capital is the focal point of one of the most dynamic regions in Northern Europe. Here are some tips on where to spend your ti...

Ny vd på Klaria

Kommer närmast från Oberland Capital.

Danisco strengthens its IP team

Danisco's division Genencor has appointed a new Vice President of Intellectual Property Strategy and Chief IP Counsel.

Major changes to the Q-Med board

The nomination committee wants to replace half of the existing board, including the current Chairman. An Extraordinary General Meeting will take place on February 4.

Nya resultat om immunförsvarets reaktion vid svår covid-19

Forskare har identifierat flera celltyper som är centrala vid immunförsvarets reaktion vid covid-19.

Oasmia gets a confirmation

FDA has granted Oasmia an expedited review status for Paclical Vet.

Elekta gets ok from China

The Swedish medtech comapny Elekta has received approval from the Chinese authority State Food and Drug Administration, SFDA, to sell its linear accelerator in China.

Ny metod förutser lovande läkemedel

Enligt en ny studie kan forskningsbolaget Attanas teknik förbättra lyckandegraden för kliniska studier.

Danish focus on bio chemicals

The Danish company Genencor and the German company BRAIN establish a research collaboration for the production of biobased chemicals from renewable feedstock.

Danish focus on bio chemicals

The Danish company Genencor and the German company BRAIN establish a research collaboration for the production of biobased chemicals from renewable feedstock.

Danish focus on bio chemicals

The Danish company Genencor and the German company BRAIN establish a research collaboration for the production of biobased chemicals from renewable feedstock.

Danish focus on bio chemicals

The Danish company Genencor and the German company BRAIN establish a research collaboration for the production of biobased chemicals from renewable feedstock.

Danish focus on bio chemicals

The Danish company Genencor and the German company BRAIN establish a research collaboration for the production of biobased chemicals from renewable feedstock.

Avtalet med Almirall sägs upp

Index får tillbaka de europeiska rättigheterna för läkemedelskandidaten Kappaproct mot ulcerös kolit.

LEO Pharma - International Clinical Trial Manager

Diagnostics to deal with new diseases

Maria Brytting at the Swedish Institute for Infectious Disease Control, SMI, will share her experiences from April 2009 when the new influenza A virus, H1N1, wa...

Digitalisering och kliniska prövningar

Effektivare kliniska prövningar och ny teknologi för dokumentation av behandlingar - Digitaliseringen öppnar många möjligheter. Ola Björkman rapporterar från BIO i San Diego.

Hey Klementina Österberg ...

... CEO at GU Holding, which awards SEK 120, 000 to three female entrepreneurs.

Medtech companies find new beam technique

The medtech companies Raysearch and Nucletron expand collaboration with two new solutions for radiation treatment planning.

Crafoord Prize to an American and two Japanese

Today the Royal Swedish Academy of Sciences announces the laureates of the Crafoord Prize in Polyarthritis 2009.

Analytisk kemi nytt ben för Recipharm

CDMO Recipharm lanserar en fristående tjänst inom analytisk kemi.

New CEO to Swedish Tillotts Pharma

The Swiss company Tillotts Pharma's newly established Swedish organisation has appointed a CEO from Bayer Scandinavia.

Trio goes in for high tech medicines

The Swedish drug discovery company Beactica announces fragment-based drug discovery research collaboration with GE Healthcare and the University of Uppsala.

Parnevik firm in Swiss osteoporosis deal

The golf legend Jesper Parnevik's drug delivery firm EffRx has signed a license agreement with Nycomed for a new drug against osteoporosis.